FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for pravastatin sodium submitted by Teva Pharmaceuticals USA, Inc. under ANDA 076056. The action relates to a modificati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Dyslipidemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)